We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 39,309

Select HIPAA privacy and security enforcement actions
  • Cooley LLP
  • USA
  • May 27 2015

Cornell disposed of unsecured documents containing PHI of 1,610 patients in unlocked, open dumpster accessible to the public OCR’s


Patent safe harbor applies to supplemental new drug applications
  • Foley & Lardner LLP
  • USA
  • May 21 2015

On May 13, 2015, the Federal Circuit confirmed in Classen Immunotherapies, Inc. v. Elan Pharmaceuticals, Inc. that the safe harbor provisions of 35 U


Shaking down the thunder from the sky: part 2 of notre dame's challenge to the contraception mandate
  • Foley & Lardner LLP
  • USA
  • May 21 2015

For the second time in as many years, the Seventh Circuit has declined to grant Notre Dame’s request for an injunction exempting the university from


Increased audit activity concerning Health Care Reform compliance
  • Phelps Dunbar LLP
  • USA
  • May 21 2015

In recent months, the Department of Labor (DOL) has increased enforcement activity related to the Affordable Care Act (the ACA), commonly known as


DEA announces major enforcement action
  • Quarles & Brady LLP
  • USA
  • May 21 2015

On May 20, 2015, DEA issued a press release regarding a recent major enforcement action in Arkansas, Alabama, Louisiana, and Mississippi. Operation


CMS releases broad data on prescribing patterns of physicians and providers under Medicare Part D
  • McDermott Will & Emery
  • USA
  • May 21 2015

In a highly anticipated and scrutinized decision, the Centers for Medicare & Medicaid Services (CMS) released a new public data set on April 30, 2015


FDA addresses compounding of animal drugs from bulk drug substances
  • Baker & Hostetler LLP
  • USA
  • May 21 2015

The U.S. Food and Drug Administration (FDA) has released a Notice of Draft Guidance and Withdrawal of Compliance Policy Guidance (Guidance Notice


Carbon nanotubes offer big technological advantages
  • Greenberg Traurig LLP
  • USA
  • May 21 2015

A few decades ago, we knew of only a few forms of carbon: diamond, graphite, and amorphous carbon. Today, thanks to rapid scientific advancements in


CMS schedules August 24-25, 2015 OPPS Advisory Panel meeting
  • Reed Smith LLP
  • USA
  • May 21 2015

CMS has announced that it is holding a meeting of the Advisory Panel on Hospital Outpatient Payment on August 24-25, 2015. The purpose of the Panel is


Life Sciences IPR Final Written Decision; Touches on Written Description, 102 and 103
  • Fish & Richardson PC
  • USA
  • May 20 2015

Life Sciences IPR Final Written Decision; Touches on Written Description (in determining whether or not priority claim is valid), 102 and 103